Timing matters: study tests best way to take kidney and blood pressure meds together
NCT ID NCT01976572
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 1 trial looked at how colestilan, a drug for high phosphate levels in kidney disease, affects the body's processing of candesartan, a blood pressure medication. Eighteen healthy men took candesartan alone or with colestilan at different times. The goal was to see if colestilan changes candesartan levels in the blood, which could help doctors recommend the best dosing schedule for patients who need both drugs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- colestilan and candesartan
- What this could lead to
- If successful, this could help doctors decide the best timing for taking colestilan and candesartan together to avoid drug interactions in people with kidney disease.
- What could go wrong
- This was a small, early-stage study in healthy volunteers, not patients. Results may not directly apply to people with kidney disease or other health conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Covance Clinical Research Unit Ltd.
Leeds, Springfield House Hyde Street, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Aging kidneys under the microscope: could a simple test predict failure?
- Could your gut bacteria hold the key to protecting your kidneys?
- Food as medicine: could cooking classes slow kidney disease?
- Could a phone app be the key to managing kidney disease?
- A new pill aims to slow kidney failure and save lives
- AI takes on kidney disease: a new model to forecast Who's at risk